Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.
Morrissey DV; Lockridge JA; Shaw L; Blanchard K; Jensen K; Breen W; Hartsough K; Machemer L; Radka S; Jadhav V; Vaish N; Zinnen S; Vargeese C; Bowman K; Shaffer CS; Jeffs LB; Judge A; MacLachlan I; Polisky B; Nature Biotechnology, 2005, vol. 23, issue 8, p 1002, ISSN 10870156. ISBN 10870156.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef